Cross-Border Emergence of Escherichia coli Producing the Carbapenemase NDM-5 in Switzerland and Germany.

Bacterial Proteins Escherichia coli / genetics Europe Germany Humans Microbial Sensitivity Tests Phylogeny Plasmids / genetics Switzerland beta-Lactamases / genetics
Escherichia coli NDM NDM-5 ST167 WGS plasmid replicon whole-genome sequencing

Journal

Journal of clinical microbiology
ISSN: 1098-660X
Titre abrégé: J Clin Microbiol
Pays: United States
ID NLM: 7505564

Informations de publication

Date de publication:
18 02 2021
Historique:
received: 26 08 2020
accepted: 04 12 2020
pubmed: 29 12 2020
medline: 9 7 2021
entrez: 28 12 2020
Statut: epublish

Résumé

A series of clinical NDM-5-producing

Identifiants

DOI: 10.1128/JCM.02238-20 PMID: 33361340 PMC: PMC8106709
pubmed: 33361340
pii: JCM.02238-20
doi: 10.1128/JCM.02238-20
pmc: PMC8106709
pii:
doi:

Substances chimiques

Bacterial Proteins 0
beta-Lactamases EC 3.5.2.6
carbapenemase EC 3.5.2.6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2021 American Society for Microbiology.

Références

Int J Antimicrob Agents. 2009 Aug;34(2):173-6
pubmed: 19464856
Antimicrob Agents Chemother. 2011 Nov;55(11):5403-7
pubmed: 21859933
Antimicrob Agents Chemother. 2014 Dec;58(12):7548-52
pubmed: 25246393
PLoS Comput Biol. 2020 Mar 5;16(3):e1007134
pubmed: 32134915
Zoonoses Public Health. 2020 May;67(3):324-329
pubmed: 31867850
mSphere. 2019 Mar 13;4(2):
pubmed: 30867330
Iran J Microbiol. 2015 Oct;7(5):226-46
pubmed: 26719779
Antimicrob Agents Chemother. 2016 Jun 20;60(7):4364-8
pubmed: 27114282
mSphere. 2020 Apr 29;5(2):
pubmed: 32350092
J Glob Antimicrob Resist. 2018 Dec;15:226-227
pubmed: 30339894
Antimicrob Agents Chemother. 2015 Jan;59(1):659-62
pubmed: 25313215
mSystems. 2019 Feb 26;4(1):
pubmed: 30834329
J Infect Dis. 2017 Feb 15;215(suppl_1):S28-S36
pubmed: 28375512
Lancet Infect Dis. 2010 Sep;10(9):597-602
pubmed: 20705517
J Antimicrob Chemother. 2018 Dec 1;73(12):3523-3526
pubmed: 30189008
J Glob Antimicrob Resist. 2020 Dec;23:70-71
pubmed: 32889140
Clin Microbiol Infect. 2012 May;18(5):E144-8
pubmed: 22404169
J Clin Microbiol. 2020 Aug 24;58(9):
pubmed: 32580949
Euro Surveill. 2019 Dec;24(50):
pubmed: 31847948
Environ Microbiol Rep. 2013 Feb;5(1):58-65
pubmed: 23757131
Int J Antimicrob Agents. 2018 Jul;52(1):76-81
pubmed: 29501819
J Clin Microbiol. 2019 Jan 2;57(1):
pubmed: 30381418
Euro Surveill. 2010 Nov 18;15(46):
pubmed: 21144431
Euro Surveill. 2018 Jul;23(27):
pubmed: 29991384
J Antimicrob Chemother. 2020 Mar 1;75(3):766-768
pubmed: 31819979
J Med Microbiol. 2013 Jul;62(Pt 7):1044-1050
pubmed: 23579399
Diagn Microbiol Infect Dis. 2011 May;70(1):119-23
pubmed: 21398074
Sci Rep. 2016 Jul 13;6:29934
pubmed: 27406405
Genome Biol. 2014;15(11):524
pubmed: 25410596
J Antimicrob Chemother. 2013 Aug;68(8):1741-9
pubmed: 23599361
Future Microbiol. 2014;9(1):33-41
pubmed: 24328379
Emerg Infect Dis. 2012 Sep;18(9):1503-7
pubmed: 22932472
Antimicrob Resist Infect Control. 2018 Apr 26;7:59
pubmed: 29713466
J Antimicrob Chemother. 2018 Sep 1;73(9):2340-2346
pubmed: 29897467
J Antimicrob Chemother. 2013 Aug;68(8):1737-40
pubmed: 23557929
Emerg Infect Dis. 2016 Jun;22(6):1038-43
pubmed: 27191712
Ann Lab Med. 2018 May;38(3):277-279
pubmed: 29401566
J Antimicrob Chemother. 2020 Apr 1;75(4):903-906
pubmed: 31971235
Antimicrob Agents Chemother. 2011 Dec;55(12):5952-4
pubmed: 21930874

Auteurs

Trinad Chakraborty (T)

Institute of Medical Microbiology, Partner Site Giessen-Marburg-Langen, Justus Liebig University Giessen, Giessen, Germany.
German Center for Infection Research (DZIF), Partner Site Giessen-Marburg-Langen, Justus Liebig University Giessen, Giessen, Germany.

Mustafa Sadek (M)

Medical and Molecular Microbiology, Section of Medicine, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland.

Yancheng Yao (Y)

Institute of Medical Microbiology, Partner Site Giessen-Marburg-Langen, Justus Liebig University Giessen, Giessen, Germany.
German Center for Infection Research (DZIF), Partner Site Giessen-Marburg-Langen, Justus Liebig University Giessen, Giessen, Germany.

Can Imirzalioglu (C)

Institute of Medical Microbiology, Partner Site Giessen-Marburg-Langen, Justus Liebig University Giessen, Giessen, Germany.
German Center for Infection Research (DZIF), Partner Site Giessen-Marburg-Langen, Justus Liebig University Giessen, Giessen, Germany.

Roger Stephan (R)

Institute for Food Safety and Hygiene, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
ORCID: 0000-0003-1002-4762

Laurent Poirel (L)

Medical and Molecular Microbiology, Section of Medicine, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland.
INSERM European Unit (IAME, France), University of Fribourg, Fribourg, Switzerland.
Swiss National Reference Center for Emerging Antibiotic Resistance (NARA), University of Fribourg, Fribourg, Switzerland.
ORCID: 0000-0001-5160-5286

Patrice Nordmann (P)

Institute for Microbiology, University Hospital Centre, Lausanne, Switzerland patrice.nordmann@unifr.ch.
Medical and Molecular Microbiology, Section of Medicine, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland.
INSERM European Unit (IAME, France), University of Fribourg, Fribourg, Switzerland.
Swiss National Reference Center for Emerging Antibiotic Resistance (NARA), University of Fribourg, Fribourg, Switzerland.
ORCID: 0000-0002-1343-1622

Articles similaires

Comprehensive comparative analysis and development of molecular markers for Lasianthus species based on complete chloroplast genome sequences.

Yue Zhang, Meifang Song, Deying Tang et al.
1.00
Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH

questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines bactériennes › Cross-Border Emergence of Escherichia coli...
questionsmedicales.fr › Bactéries › Proteobacteria › Gammaproteobacteria › Enterobacteriaceae › Escherichia › Escherichia coli › Cross-Border Emergence of Escherichia coli...
questionsmedicales.fr › Régions géographiques › Europe › Cross-Border Emergence of Escherichia coli...
questionsmedicales.fr › Régions géographiques › Europe › Allemagne › Cross-Border Emergence of Escherichia coli...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Cross-Border Emergence of Escherichia coli...
questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Tests de sensibilité microbienne › Cross-Border Emergence of Escherichia coli...
questionsmedicales.fr › Sciences de l'information › Phylogenèse › Cross-Border Emergence of Escherichia coli...
questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Plasmides › Cross-Border Emergence of Escherichia coli...
questionsmedicales.fr › Régions géographiques › Europe › Suisse › Cross-Border Emergence of Escherichia coli...
questionsmedicales.fr › Enzymes et coenzymes › Enzymes › Hydrolases › Amidohydrolases › bêta-Lactamases › Cross-Border Emergence of Escherichia coli...